Given the fact that chronic wounds affect two million people in France, and that treatment options are often costly and ill-suited to the patient, it is clear that more appropriate solutions need to be found. That’s what we’ve set out to do with Grapheal - Advanced Wound Care. Its goal? To optimise the treatment of these chronic wounds using next-generation bandages.

Using the properties of graphene, which its members have studied for years, the Grenoble-based startup Grapheal has developed a new smart material, classified as non-toxic by a certified body. When embedded into bandages, it helps chronic wounds heal more quickly using electrostimulation. And the solution doesn’t stop there: it also allows you to remotely monitor the condition of a wound using biosensors. With the rise of telemedicine, these smart bandages will allow patients to receive at-home care and improve their quality of life.

After more than ten years of research at the French National Centre for Scientific Research (French: Centre national de la recherche scientifique, CNRS), the Grapheal founders selected the pharmaceutical market. First conceived for chronic wounds, Grapheal’s applications could be endless. The Jury of the 2019 EDF Pulse start-up Awards recognised the strength and potentials of the team by awarding them 3rd place on the podium.